Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, April 12, 2012
[ 07:41 AM ] - United States, WOPRAI
[ 07:41 AM ] - United States, WOPRAI
[ 07:41 AM ] - United States, WOPRAI
[ 07:41 AM ] - United States, WOPRAI
[ 07:40 AM ] - United States, WOPRAI
[ 07:40 AM ] - United States, WOPRAI
[ 07:40 AM ] - United States, WOPRAI
[ 07:40 AM ] - United States, WOPRAI
[ 07:40 AM ] - United States, WOPRAI
[ 06:47 AM ] - United States, Market Wire
[ 06:47 AM ] - United States, Market Wire
[ 06:20 AM ] - United States, WOPRAI
[ 06:15 AM ] - United States, Market Wire
[ 06:01 AM ] - United States, Market Wire
[ 06:00 AM ] - United States, Market Wire
[ 05:41 AM ] - United States, WOPRAI
[ 05:40 AM ] - United States, WOPRAI
[ 05:40 AM ] - United States, WOPRAI
[ 05:40 AM ] - United States, WOPRAI
[ 05:40 AM ] - United States, WOPRAI
[ 05:00 AM ] - United States, Market Wire
[ 05:00 AM ] - United States, Market Wire
[ 04:39 AM ] - United States, Market Wire
[ 04:20 AM ] - United States, WOPRAI
[ 04:00 AM ] - United States, Market Wire
[ 12:00 AM ] - United States, WOPRAI
Martin Auster Initiated (BMRN) at Strong Buy and Held Target at $43 on, Apr 12th, 2012
Martin Auster of UBS, Initiated "BioMarin Pharmaceutical Inc." (BMRN) at Strong Buy and Held Target at $43 on, Apr 12th, 2012.
Martin has made no other calls on BMRN in the last 4 months.
There is 1 other peer that has a rating on BMRN. Out of the 1 peers that are also analyzing BMRN, 0 agree with Martin's Rating of Hold.
This is the rating of the analyst that currently disagrees with Martin
- Michelle Gilson of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $43 on, Monday, March 26th, 2012
